Jean Charles Soria Selected Research

Jean Charles Soria Research Topics

Disease

20	Neoplasms (Cancer) 01/2020 - 05/2004
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 07/2007
4	Proteinuria 11/2014 - 01/2010
3	Melanoma (Melanoma, Malignant) 03/2018 - 03/2007
3	Lung Neoplasms (Lung Cancer) 05/2014 - 09/2005
3	Carcinoma (Carcinomatosis) 07/2012 - 03/2005
3	Carcinogenesis 08/2008 - 05/2004
2	Disease Progression 01/2018 - 05/2004
2	Hypertension (High Blood Pressure) 11/2014 - 03/2010
2	Kidney Diseases (Kidney Disease) 11/2014 - 01/2010
2	Diarrhea 06/2013 - 03/2007
2	Fatigue 06/2013 - 03/2007
2	Thrombotic Microangiopathies 03/2010 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 12/2006 - 05/2004
1	COVID-19 01/2020
1	Anaplastic Thyroid Carcinoma 01/2018
1	Renal Insufficiency (Renal Failure) 09/2013
1	Febrile Neutropenia 06/2013
1	Neutropenia 06/2013
1	Thrombocytopenia (Thrombopenia) 06/2013
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Sarcoma (Soft Tissue Sarcoma) 05/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Adenocarcinoma 01/2013
1	Sudden Death 12/2011
1	Cardiotoxicity 12/2011
1	Necrosis 03/2010
1	Hypophosphatemia 03/2010
1	Neoplasm Metastasis (Metastasis) 08/2008
1	Colonic Neoplasms (Colon Cancer) 08/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2007
1	Alopecia (Baldness) 03/2007
1	Nausea 03/2007
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2006
1	Large Cell Carcinoma 09/2005
1	Metaplasia 03/2005
1	Carcinoma in Situ 03/2005

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 01/2010
4	Pharmaceutical PreparationsIBA 11/2014 - 03/2007
3	Proteins (Proteins, Gene)FDA Link 01/2010 - 03/2005
2	LigandsIBA 11/2020 - 03/2013
2	Immune Checkpoint InhibitorsIBA 11/2020 - 03/2018
2	Phosphotransferases (Kinase)IBA 12/2011 - 01/2005
2	Sorafenib (BAY 43-9006)FDA Link 01/2010 - 03/2007
2	Aquaporin 5IBA 08/2008 - 05/2008
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2018
1	dabrafenibIBA 01/2018
1	trametinibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 11/2014
1	Cisplatin (Platino)FDA LinkGeneric 05/2014
1	Immunomodulating AgentsIBA 01/2014
1	Cadherins (E-Cadherin)IBA 06/2013
1	VimentinIBA 06/2013
1	CrizotinibIBA 06/2013
1	PM 00104IBA 06/2013
1	Lipase (Acid Lipase)FDA Link 06/2013
1	AVE1642IBA 05/2013
1	Biological ProductsIBA 03/2013
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	Angiogenesis InhibitorsIBA 12/2011
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 12/2011
1	Tyrosine (L-Tyrosine)FDA Link 12/2011
1	ElectrolytesIBA 03/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2010
1	Sunitinib (Sutent)FDA Link 01/2010
1	Bevacizumab (Avastin)FDA Link 01/2010
1	afliberceptIBA 01/2010
1	pazopanib FDA Link 01/2010
1	nephrinIBA 01/2010
1	Axitinib (AG 013736)IBA 01/2010
1	Aquaporins (Water Channels)IBA 08/2008
1	Threonine (L-Threonine)FDA Link 08/2008
1	Retinoblastoma ProteinIBA 08/2008
1	Mitogen-Activated Protein Kinase 3IBA 08/2008
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2008
1	Serine (L-Serine)FDA Link 08/2008
1	ErbB Receptors (EGF Receptor)IBA 07/2007
1	Tyrosine Kinase InhibitorsIBA 07/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2007
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	HLA-A*02:01 antigenIBA 12/2006
1	Peptides (Polypeptides)IBA 12/2006
1	Complementary DNA (cDNA)IBA 12/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2005
1	CytokinesIBA 09/2005
1	Interferon-gamma (Interferon, gamma)IBA 09/2005
1	AntigensIBA 09/2005
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2005
1	Messenger RNA (mRNA)IBA 03/2005

Therapy/Procedure

7	Therapeutics 01/2020 - 05/2004
6	Drug Therapy (Chemotherapy) 11/2020 - 09/2005
2	Immunotherapy 01/2014 - 12/2006
1	Radiotherapy 07/2012
1	Molecular Targeted Therapy 12/2011